β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes

  1. Sophie Schobesberger
  2. Peter T Wright
  3. Claire Poulet
  4. Jose L Sanchez Alonso Mardones
  5. Catherine Mansfield
  6. Andreas Friebe
  7. Sian E Harding
  8. Jean-Luc Balligand
  9. Viacheslav O Nikolaev  Is a corresponding author
  10. Julia Gorelik  Is a corresponding author
  1. Imperial College London, United Kingdom
  2. University of Würzburg, Germany
  3. Université Catholique de Louvain, Belgium
  4. Universitätsklinikum Hamburg Eppendorf, Germany

Abstract

Cardiomyocyte b3-adrenoceptors (b3-ARs) coupled to soluble guanylyl cyclase (sGC)-dependent production of the second messenger 3',5'-cyclic guanosine monophosphate (cGMP) have been shown to protect from heart failure. However, the exact localization of these receptors to fine membrane structures and subcellular compartmentation of b3-AR/cGMP signals underpinning this protection in health and disease remain elusive. Here, we used a Förster Resonance Energy Transfer (FRET)-based cGMP biosensor combined with scanning ion conductance microscopy (SICM) to show that functional β3-ARs are mostly confined to the T-tubules of healthy rat cardiomyocytes. Heart failure, induced via myocardial infarction, causes a decrease of the cGMP levels generated by these receptors and a change of subcellular cGMP compartmentation. Furthermore, attenuated cGMP signals led to impaired phosphodiesterase 2 dependent negative cGMP-to-cAMP cross-talk. In conclusion, topographic and functional reorganization of the b3-AR/cGMP signalosome happens in heart failure and should be considered when designing new therapies acting via this receptor.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files are provided for all figures to eLife journal.

Article and author information

Author details

  1. Sophie Schobesberger

    Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8268-0019
  2. Peter T Wright

    Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Claire Poulet

    Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Jose L Sanchez Alonso Mardones

    Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Catherine Mansfield

    Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Andreas Friebe

    Physiologisches Institut, University of Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Sian E Harding

    Myocardial Function, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Jean-Luc Balligand

    FATH Pole, Université Catholique de Louvain, Louvain, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  9. Viacheslav O Nikolaev

    Experimentelle Herz Kreislaufforschung, Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
    For correspondence
    v.nikolaev@uke.de
    Competing interests
    The authors declare that no competing interests exist.
  10. Julia Gorelik

    National Heart and Lung Institute, Imperial College London, London, United Kingdom
    For correspondence
    j.gorelik@imperial.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1148-9158

Funding

British Heart Foundation (12/18/30088)

  • Julia Gorelik

Wellcome (WT090594)

  • Julia Gorelik

Deutsche Forschungsgemeinschaft (Fr 1725/3-2)

  • Andreas Friebe
  • Viacheslav O Nikolaev

National Institutes of Health (ROI-HL grant 126802)

  • Julia Gorelik

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures performed in the UK were carried out according to the standards for the care and use of animal subjects determined by the UK Home Office (ASPA1986 Amendments Regulations 2012) incorporating the EU directive 2010/63/EU. The Animal Welfare and Ethical Review Body Committee of Imperial College London approved all protocols.The parts of the investigation, which were performed in Germany, conformed to the guide for the care and use of laboratory animals published by the National Institutes of Health (Bethesda, Maryland; Publication No. 85-23, revised 2011, published by National Research Council, Washington, D.C.). The experimental procedures were in accordance with the German Law for the Protection of Animals and with the guidelines of the European Community.

Copyright

© 2020, Schobesberger et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,275
    views
  • 214
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sophie Schobesberger
  2. Peter T Wright
  3. Claire Poulet
  4. Jose L Sanchez Alonso Mardones
  5. Catherine Mansfield
  6. Andreas Friebe
  7. Sian E Harding
  8. Jean-Luc Balligand
  9. Viacheslav O Nikolaev
  10. Julia Gorelik
(2020)
β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes
eLife 9:e52221.
https://doi.org/10.7554/eLife.52221

Share this article

https://doi.org/10.7554/eLife.52221

Further reading

    1. Cell Biology
    Ling Cheng, Ian Meliala ... Mikael Björklund
    Research Article

    Mitochondrial dysfunction is involved in numerous diseases and the aging process. The integrated stress response (ISR) serves as a critical adaptation mechanism to a variety of stresses, including those originating from mitochondria. By utilizing mass spectrometry-based cellular thermal shift assay (MS-CETSA), we uncovered that phosphatidylethanolamine-binding protein 1 (PEBP1), also known as Raf kinase inhibitory protein (RKIP), is thermally stabilized by stresses which induce mitochondrial ISR. Depletion of PEBP1 impaired mitochondrial ISR activation by reducing eukaryotic translation initiation factor 2α (eIF2α) phosphorylation and subsequent ISR gene expression, which was independent of PEBP1’s role in inhibiting the RAF/MEK/ERK pathway. Consistently, overexpression of PEBP1 potentiated ISR activation by heme-regulated inhibitor (HRI) kinase, the principal eIF2α kinase in the mitochondrial ISR pathway. Real-time interaction analysis using luminescence complementation in live cells revealed an interaction between PEBP1 and eIF2α, which was disrupted by eIF2α S51 phosphorylation. These findings suggest a role for PEBP1 in amplifying mitochondrial stress signals, thereby facilitating an effective cellular response to mitochondrial dysfunction. Therefore, PEBP1 may be a potential therapeutic target for diseases associated with mitochondrial dysfunction.

    1. Cell Biology
    Nancy Nader, Lama Assaf ... Khaled Machaca
    Research Article

    The steroid hormone progesterone (P4) regulates multiple aspects of reproductive and metabolic physiology. Classical P4 signaling operates through nuclear receptors that regulate transcription. In addition, P4 signals through membrane P4 receptors (mPRs) in a rapid nongenomic modality. Despite the established physiological importance of P4 nongenomic signaling, the details of its signal transduction cascade remain elusive. Here, using Xenopus oocyte maturation as a well-established physiological readout of nongenomic P4 signaling, we identify the lipid hydrolase ABHD2 (α/β hydrolase domain-containing protein 2) as an essential mPRβ co-receptor to trigger meiosis. We show using functional assays coupled to unbiased and targeted cell-based lipidomics that ABHD2 possesses a phospholipase A2 (PLA2) activity that requires mPRβ. This PLA2 activity bifurcates P4 signaling by inducing clathrin-dependent endocytosis of mPRβ, resulting in the production of lipid messengers that are G-protein coupled receptor agonists. Therefore, P4 drives meiosis by inducing an ABHD2 PLA2 activity that requires both mPRβ and ABHD2 as obligate co-receptors.